Crossref
Cardiovascular polypharmacy for atherosclerotic cardiovascular disease, therapeutic goals and targets: Are we doing the right thing?
ASEAN Heart Journal · 2019
DOI: 10.31762/ahj1926.0201 ↗Kurz gefasst
Fachartikel in der Zeitschrift ASEAN Heart Journal, 2019. Verfasst von David KL Quek.
Themen: Medikationssicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Quek, D. K. (2019). Cardiovascular polypharmacy for atherosclerotic cardiovascular disease, therapeutic goals and targets: Are we doing the right thing?. ASEAN Heart Journal. https://doi.org/10.31762/ahj1926.0201
Vancouver
Quek DK. Cardiovascular polypharmacy for atherosclerotic cardiovascular disease, therapeutic goals and targets: Are we doing the right thing?. ASEAN Heart Journal. 2019. doi:10.31762/ahj1926.0201
BibTeX
@article{Quek2019,
author = {Quek, David KL},
title = {Cardiovascular polypharmacy for atherosclerotic cardiovascular disease, therapeutic goals and targets: Are we doing the right thing?},
journal = {ASEAN Heart Journal},
year = {2019},
doi = {10.31762/ahj1926.0201}
}
EUVIMED